rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael Kelly

Director

Company insider

Files Form 4 as: Director, ARS Pharmaceuticals.

In numbers

Trades disclosed
8
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
8 Nov 2022
Last trade
24 Jun 2026
Last filed
26 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
SPRY ARS PharmaceuticalsDirector · Pharmaceuticals · last 24 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
24 Jun 2026filed 26 Jun 2026SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—30,000 at $0.00filing
24 Jun 2026filed 26 Jun 2026SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—30,000 at $0.00filing
25 Jun 2025filed 27 Jun 2025SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—30,000 at $0.00filing
20 Jun 2024filed 24 Jun 2024SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—40,000 at $0.00filing
27 Jun 2023filed 28 Jun 2023SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—40,000 at $0.00filing
8 Nov 2022filed 10 Nov 2022SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—70,422filing
8 Nov 2022filed 10 Nov 2022SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—118,190filing
8 Nov 2022filed 10 Nov 2022SPRY ARS PharmaceuticalsPharmaceuticalsSEC FORM 4 Code A—83,225filing

Sectors

No trade we could place in a sector.

Related people

Donn CasalePresident and CEO · President and CEO at ARS Pharmaceuticals, filing Form 4 there in the last year
Margaret Ekins SmithChief Commercial Officer · Chief Commercial Officer at ARS Pharmaceuticals, filing Form 4 there in the last year
RA CAPITAL MANAGEMENT, L.P.Director and 10% owner · Director and 10% owner at ARS Pharmaceuticals, filing Form 4 there in the last year
Peter A. ThompsonDirector · Director at ARS Pharmaceuticals, filing Form 4 there in the last year
Saqib IslamDirector · Director at ARS Pharmaceuticals, filing Form 4 there in the last year